Busy. Please wait.
or

show password
Forgot Password?

Don't have an account?  Sign up 
or

Username is available taken
show password

why


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.
We do not share your email address with others. It is only used to allow you to reset your password. For details read our Privacy Policy and Terms of Service.


Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.

Remove ads
Don't know
Know
remaining cards
Save
0:01
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
Retries:
restart all cards




share
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

Mammary Immunology 2

QuestionAnswer
CMT Measures nuclear DNA, more cells = more DNA = stickier = more clumping
SCC Beneficial Migrate rapidly and in sufficient numbers during early stages of infection, function properly and eliminate bacteria effectively, return to low levels quickly
SCC Detrimental Delayed migration, unable to control rapid growth of bacteria, elevated numbers persist for a long period of time
N-acetyl-B-D Glucosaminidase (NAGase) Lysosomal enzyme increased during mastitis, comes from immune cells
Mastitis Control Program Udder health goals, clean/dry environment, proper milking procedure, milking equipment, record keeping, clinical mastitis management, dry cow management, biosecurity, monitor udder health, review
Inhibitors of Cell Wall Synthesis Beta-lactams (penicillins and cephalosporins), polypeptides (bacitracin), and vancomycin - inhibit when bacteria is actively growing
Inhibitors of Protein Synthesis Macrolides (erythromycin), lincosamides (clindamycin), and chloramphenicol bind 50s subunit, animonglycosides (genatmycin, amikacin) and tetracyclines bind 30s subunit - binds ribosomes to prevent function
Prevent Transcription or DNA Integrity Quinolones (norfloxacin, ciprofloxacin, enroflocacin) inhibit DNA gyrase or topoisomerase, rifamycins (rifampin) inhibit mRNA formation and transcription
Antibiotics Time and concentration dependent, antimicrobial resistance dependent
Gene Transfer Transduction: through phage or virus, conjugation: through pili, competance: release of DNA into the environment and accepted through phagocytosis
Resistance Microbe produces enzyme that destroys antibiotic, microbial enzyme added to antibiotic structure, changes in cell wall permeability, changes in target protein, transport or antibiotic out of cell
Contagious Pathogens Streptococcus agalactiae (eradicated bc obligate of mammary gland), Staphylococcus aureus, Corynebacterium bovis (monitoring tool) - source usually infected udders, transmission at milking, usually chronic subclinical
Environmental Pathogens Source is cows environment, transmission between milkings, higher incidence in herds that control contagious pathogens, infections during dry period and at calving, less responsive to mastitis control practices
Opportunistic Pathogens Source is healthy teat skin + milkers hands, transmission due to bacterial load on teat end, most common bacteria in herd, no effect on milk production, eliminated with teat dip and dry cow therapy, responsive to antibiotics, protection from others
Uncommon Mastitis Pathogens Psuedomonas aeruginosa from contaminated water/teat dip, Nocardia species from soil and bad infusions, Actinomyces pyogenes from soil, Mycoplasma species contagious, preceded by respiratory disease
Staphylococcal Species Catalase positive, produce catalase enzyme, degrade hydrogen peroxide to water and O2, gram + cocci, haemolysis (a green, b clear zone, y none), thick cell wall, SA coagulase positive
Pathogenicity Ability to infect a host
Pathogenic Disease causing
Virulence Ability to cause disease in the infected host, bacterial properties that enhance disease-producing capabilities, avirulent = cant cause disease
S. aureus Gram (+) cocci, colonize skin, nasal cavity, and mucosal membranes, thrive on unhealthy skin, coagulase positive, b haemolysis - pathogen wins 70-80% of the time, cause clots = shed in cyclic manner
Abscess Formation by SA Host attempts for confine bacteria, wall off bacteria with scar tissue = poor antibiotic cure rates, SA can break through accesses
Virulence Factors Any characteristic the bacteria produces that can increase the chance for infecting a host, causing disease, prolonging disease, or altering the severity of a disease
Surface Factors Cell envelope teichoic/lipoteichoic acid, peptidoglycan, protein A, pseudocapsules, slime, adhesins,
Teichoic/Lipoteichoic Acid AFFECTS ERYTHROCYTES, activates complement, hypersensitivity, adhesion to host cells, biofilm formation, covalently bound to peptidoglycan, specific antibodies - antigenic determinant
Peptidoglycan Affected by growth conditions, pyrogenic effects (TNF, IL 1/6), aggregation and lysis of blood platelets, INHIBITS LEUKOCYTE MIGRATION, purulent lesion, specific antibodies, biosynthetic function, active transport
Protein A Cell wall component, 90-98% SA, inhibits opsonization through Fc binding, blood coagulation, platelet damage, 1 protein A binds two Ig,, resists milk flushing
Pseudocapsules Polysaccharide surface, frequently observed on fresh isolates and those grown in milk, acts as a PHYSICAL BARRIER for C3 and antigen masking, type 5 and 8 in 70-80% of strains, evade complement
Slime Diffuse capsule, heterogeneous in composition, saccharides, neutral sugars and amino acids, poor antigen - no specific antibodies against it, anti-phagocytic
Adhesins Surface protein: affinity for fibronectin, collagen, laminin, fibrinogen, resists flushing effect of milking Cell wall anchored proteins: collagen and fibrinogen binding protein, clumping factor A and B, fibronectin binding proteins
Secreted Factors Coagulase, enterotoxins, superantigen, haemolysins, A/B/Y toxins, hyaluronidase, lipase, catalase, nuclease, fatty acid modifying enzyme, Panton-Valentine leukocidin, staphylokinase
Coagulase Protein that binds prothrombin and converts fibrinogen to fibrin, heterogeneous, encourages walling off of SA
Enterotoxins Associated with foodborne illness, diarrhea and vomiting, 8 types, TSST-1, produced during infection by 4-83% of isolates, act as mitogen/superantigen causing nonspecific expansion of T cells
Superantigen Overproduction of IL2, causes clonal expansion of all T cells nonspecifically
Haemolysins A/B/Y/D four types, ability to lyse red blood cells, significance as virulence factors vary, CNS cannot perform haemolysis
Hyaluronidase Break down tissue structure
A Toxin Binds plasma membrane of epithelial cells, pore formation, osmotic lysis, teat cells more resistant, secretory cells more sensitive, septic shock
B Toxin Makes cell more susceptible to A toxin, cytotoxic to secretory epithelial cells
Y Toxin Binds and damages cell membranes, activates various cells
Panton-Valentine Leukocidin 2 components acting in synergy, kills leukocytes by forming pore, produced by large number of isolates from acute dermatitis, less hemolytic than A toxin, microbes form of MAC, PVL + infections more severe
Staphylokinase plasminogen activator protein, role in fibrinogen degradation, most mastitis strains do not produce this factor, degradation of clot - cyclical shedding, usually only in clinical cases
Gangrenous Mastitis SA is main bacterial agent, rapid multiplication and toxin release, blood vessel constriction, massive blood clots, restricts blood supply to affected area
SA Diseases Pneumonia, sepicemia, osteomyelitis/septic arthritis, toxic shock syndrome, wound infections, scalded skin syndrome
Colonization Adhesins, binding proteins: fibronectin, collagen, laminin, fibrinogen, surface factors: techoic acid, protein A, peptidoglycan
Host Response Lysozyme, lactoferrin, lactoperoxidase, complement, phagocytosis, antibody
Invasins Staphylokinase, hyaluronidase, extracellular enzymes: proteases, lipases, nucleases, collagenase, elastase
Resistance to Phagocytosis Coagulase, protein A, leukocidin, hemolysins, carotenoids, superoxide dismutase, catalase, antigenic variation, growth at low pH
Resistance to Immune Response Coagulase, antigenic variation
Host Response Cell activation (TCR MHCII binding), cytokine production/adhesion molecule, apoptosis
Toxigenesis TSST toxin, enterotoxins A-G, cytotoxic toxins (hemolysins and leukocidin)
Host Response Disease
MRSA Small red bumps to abscesses, rapid blood test, SR assay using positive blood culture, PCR to test for SA and MR,
CNS Infections Bacteremia, endocarditis, UTI, surgical site infections, endophthalmitis, colonization of indwelling plastic devices, infections in preterm infants
CNS Virulence Capsular polysaccharide, biofilm formation, adhesins, protection from chemotaxis, phagocytosis, resistance to host microbial peptides, lipoteichoic acids and peptidoglycan, antibiotic resistance genes
Inactivated Vaccine Virulent micro-organism killed with chemicals or heat - Polio, pertussis, influenza, J5
Live, Attenuated Live miro-organism with disabled virulent properties but intact ability to simulate immunity - influenza and lyme
Toxoid Inactivated toxic compounds from microoganisms - tetnus
Heterologous Vaccine Microorganism that shares cross-reacting antigens with the microorganism that causes the disease - cowpox, smallpox, BCG vaccine for tuberculosis
Subunit Fragment of an organism that can create an immune response - HepB
Goals of SA Vaccine Eliminate chronic infections, reduce clinical mastitis, prevent new infections
Staph-Vax-Conjugate Capsular polysaccharide 5+8 + pseudomonas exotoxin A, phase III human trials showed reduction in bacteremia but short lasting
A-Hemolysin Protective against pneumonia in mouse model, prevents lung epithelial cell lysis, protected damage to lung which helped control bacterial growth and focused the immune response
PVL Tested in same context as A hemolysin - not protective
RIP AGR Inhibitor No toxin production, decreased biofilm formation, target protein within system can alter how SA produces and secretes toxins
Passive Immunotherapies Hyperimmune IgG preparation, anti-lipoteichoic acid monoclonal antibody for initial use in preventing staph infections in neonates
Lysostaphin Enzyme that selectively cuts through the cell wall of SA, cleaves polyglycine cross-links in the peptidoglycan layer of the cell wall of Staph species - success in transgenic species but expensive
Accessory Gene Regulator Regulates the production of Staph toxins at late stages of growth, decreases production of surface adhesion proteins and increases secreted proteins
Heteropolymer Antibodies Monocolonal antibody specific to a red blood cell receptor that is chemically linked to a second antibody that binds a particular pathogen
Mastitis Vaccines Staphoid A-B: toxin based Lysigin: includes capsular serotypes 5,8, 336, and 5 different SA strains
Vaccine Strategies Elicit antibody responses: capsular components, recombinant proteins/toxins Limited success: Protein A, low antibody titers in milk
Streptococcal Species Gram + Cocci, catalase negative, some haemolysis
Serotyping Lancefield typing (A-T) of beta hemolytic strep, based on cell surface proteins, use antibodies to recognize surface antigens, group A+B are beta hemolytic
Streptococcus agalactiae Contagious, group B, CAMP positive, obligate of udder, chronic subclinical but can be eradicated, bacteria shed in high numbers, high SCC, 85-95% cure rate with antibiotics, lower duct system
CAMP Strep ag produces a diffusible extracellular compound that in conjunction iwth beta hemolysin of SA causes complete lysis of RBC
Environmental Strep S. uberis, S. dysgalactia, S. faecalis, S. bovis ...... enterococci Infections during dry period, between milkings
Strep Virulence Factors Polysaccharide capsule, bac protein,, C5a-ase cleaves C5a, Streptolysin S and Streptolysin O, M protein, leukocidins, firbronectin binding proteins adhesions, streptokinase, hyaluronic acid capsule, strep pyrogenic exotoxins, proteases
Bac protein Binds IgA
Streptolysin S: beta hemolysin of group a strep, oxygen stable leukocidin O: oxygen labile leukocidin
M protein Adhesin, found in fimbriae, blocks binding of complement to peptidoglycan, interferes with phagocytosis, mutations alter structure rendering antibodies ineffective
Streptokinase Cleaves plasminogen to plasmin
Strep pyrogenic exotocins Types a, b, c = superantigens
Hyaluronic acid capsule Strep uberis, no changes in binding of antibody, no effect on macrophage phagocytosis, can lyse/impair function of neutrophils at high concentrations
Proteases Specific nutrient requirements for growth (AA), releases amino acids from microenvironment in mammary gland
Strep dysgalactiae Lancefield serological group C, mouth/vagina/mammary gland skin, dry cows and heifers, 50-60% cure lactation, 85% involution cure, pre dip effective
Strep dysgalactiae virulence factors IgG binding protein, hyaluronidase (digests capsule, inhibits macrophage activity), fibronectin binding protein, fibrinolysin, streptokinase (plasminogen activation)
Competence Stimulating Peptide Mediated quorum sensing system, exponential growth phase = high levels of surface associated proteins, stationary phase = high levels secreted proteins
Strep Immune Evasion Capsule: hyaluronic acid is produced, C5a peptidase: C5a enhances chemotaxis of phagocytes, M protein is fibrillar surface protein, leukocidins, production of toxins, introduce circulating cross reactive antibodies, antigenic variation and disguise
Antigenic Variation Drift: gradual accumulation of minor mutations, decreased recognition by the immune system Shift: sudden and major change in antigeniciy, failure of the immune system to recognize a new antigenic type
Created by: 1138967652782105